Carsten Hofmann

2.1k citations
43 papers · 1.3k indexed · 1 hit paper · h-index 17
Topics
Alzheimer's disease research and treatments (14 papers)Microbial Natural Products and Biosynthesis (8 papers)Health Systems, Economic Evaluations, Quality of Life (8 papers)

In The Last Decade

Carsten Hofmann

39 papers receiving 1.3k citations

Hit Papers

A phase III randomized trial of gantenerumab in prodromal...20172026202020232017100200300400

Peers

Carsten Hofmann
Comparison fields: 5 of 99
  • Physiology 623
  • Pharmacology 481
  • Molecular Biology 356
  • Psychiatry and Mental health 213
  • Computational Theory and Mathematics 169
Replace Achiel Van Peer with:
Achiel Van Peer Belgium
Trine Meldgaard Lund Denmark
Feng Guo China
Yewon Suh South Korea
Aimée Dallob United States
D. Garceau Canada
Irena Loryan Sweden
Ricardo Lehtonen Rodrigues de Souza Brazil
J. Cory Kalvass United States
Beverly Lorenzo United States
Carsten Hofmann relative to Achiel Van Peer Belgium Achiel Van Peer's profile →
Citations per field
00.5×7.7×
Achiel Van Peer · 1×
Citations per year

Countries citing papers authored by Carsten Hofmann

Since Specialization
Citations

This map shows the geographic impact of Carsten Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Hofmann more than expected).

Fields of papers citing papers by Carsten Hofmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Hofmann. The network helps show where Carsten Hofmann may publish in the future.

Co-authorship network of co-authors of Carsten Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Hofmann. A scholar is included among the top collaborators of Carsten Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Hofmann. Carsten Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 10
6 44
7 2
8 33
9 3
10
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s diseasebreakdown →
411
11 21
12 11
13 15
14 13
15 17
16 0
17 42
18 38
19 31
20
[Propofol for sedation in gastroscopy--a randomized comparison with midazolam].
16

About Carsten Hofmann

Carsten Hofmann is a scholar working on Statistics and Probability, Pharmacology and Physiology, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (14 papers), Microbial Natural Products and Biosynthesis (8 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). The work is most often cited by research in Biological Psychiatry (91 citations), Anesthesiology and Pain Medicine (167 citations) and Pharmacology (481 citations). Carsten Hofmann has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include M. Jung, Ralf Kießlich, Paul Delmar, Gregory Klein, Paulo Fontoura, Andreas Bechthold, Mirjana Andjelković, Sylvie Retout, Susanne Ostrowitzki and Kaj Blennow. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and NeuroImage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026